Technical Trend Overview and Price Movement
Fortis Healthcare’s current price stands at ₹849.50, slightly up from the previous close of ₹847.45. The stock traded within a range of ₹828.00 to ₹861.25 today, remaining well below its 52-week high of ₹1,105.00 but comfortably above the 52-week low of ₹521.05. This price action reflects a consolidation phase amid broader market volatility.
The technical trend has shifted from mildly bearish to outright bearish, signalling increased selling pressure. Daily moving averages reinforce this bearish outlook, with the stock trading below key averages, indicating a downtrend in the short term. The weekly and monthly charts provide a nuanced view, with weekly MACD and KST indicators firmly bearish, while monthly MACD and KST remain mildly bearish, suggesting that longer-term momentum is weakening but not yet decisively negative.
MACD and Momentum Indicators
The Moving Average Convergence Divergence (MACD) indicator is a critical tool for assessing momentum shifts. On the weekly timeframe, Fortis Healthcare’s MACD is bearish, reflecting a negative crossover and downward momentum. This aligns with the KST (Know Sure Thing) indicator, which also signals bearishness on a weekly basis. On the monthly scale, both MACD and KST are mildly bearish, indicating that while momentum is deteriorating, it has not yet reached extreme levels.
Relative Strength Index (RSI) readings on both weekly and monthly charts show no clear signal, hovering in neutral zones. This suggests that the stock is neither overbought nor oversold, leaving room for further directional movement depending on market catalysts.
Bollinger Bands and Volatility Insights
Bollinger Bands provide insight into price volatility and potential reversal points. Fortis Healthcare’s weekly Bollinger Bands are mildly bearish, with the price approaching the lower band, which may indicate increased downside risk or a potential support zone. Conversely, the monthly Bollinger Bands are bullish, suggesting that over a longer horizon, volatility may contract and price could stabilise or rebound.
Volume and Trend Confirmation
On-Balance Volume (OBV) indicators for both weekly and monthly periods show no definitive trend, implying that volume is not currently confirming the price movements. This lack of volume confirmation often signals caution, as price moves without strong trading support can be less sustainable.
Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!
- - Complete fundamentals package
- - Technical momentum confirmed
- - Reasonable valuation entry
Moving Averages and Dow Theory Signals
Daily moving averages for Fortis Healthcare are bearish, with the stock price trading below the 50-day and 200-day averages. This technical setup typically signals a continuation of downward momentum in the near term. The Dow Theory assessment adds further context: while the weekly timeframe shows no clear trend, the monthly Dow Theory is mildly bearish, reinforcing the cautious stance for longer-term investors.
Comparative Performance Against Sensex
Despite the recent technical deterioration, Fortis Healthcare’s longer-term returns remain impressive relative to the broader market. Year-to-date, the stock has declined by 3.85%, outperforming the Sensex’s sharper fall of 9.83%. Over the past year, Fortis has surged 30.29%, vastly outpacing the Sensex’s modest 2.25% gain. The three-year and five-year returns are even more striking, with Fortis delivering 220.26% and 323.16% respectively, compared to Sensex returns of 27.17% and 58.30%. Over a decade, the stock has appreciated by 369.99%, nearly doubling the Sensex’s 199.87% rise.
These figures highlight Fortis Healthcare’s strong fundamental growth and resilience despite recent technical setbacks, underscoring its mid-cap status and potential for recovery if momentum indicators improve.
Holding Fortis Healthcare Ltd from Hospital? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Mojo Score and Analyst Ratings
Fortis Healthcare currently holds a Mojo Score of 30.0, categorised as a Sell rating, a downgrade from its previous Hold grade as of 06 Mar 2026. This downgrade reflects the deteriorating technical parameters and the cautious outlook from MarketsMOJO’s proprietary analysis. The mid-cap company’s technical trend shift to bearish, combined with mixed signals from momentum indicators, has contributed to this reassessment.
Investors should weigh these technical warnings against Fortis’s strong historical returns and sector fundamentals. The hospital industry remains a critical segment with steady demand, but near-term price momentum suggests prudence.
Outlook and Investor Considerations
In summary, Fortis Healthcare Ltd’s technical landscape is currently dominated by bearish momentum, particularly on weekly and daily timeframes. Key indicators such as MACD, KST, and moving averages signal caution, while RSI and OBV provide no clear directional confirmation. The mixed Bollinger Bands readings suggest potential volatility ahead, with the possibility of price stabilisation over the longer term.
For investors, this means that while Fortis remains a fundamentally strong player in the hospital sector with impressive long-term returns, the immediate technical signals advise a conservative approach. Monitoring the evolution of momentum indicators and volume trends will be crucial to identifying a potential reversal or further decline.
Given the current Sell rating and bearish technical trend, investors may consider waiting for confirmation of a trend reversal or improved technical signals before increasing exposure. Those already holding the stock should remain vigilant and consider peer comparisons to optimise portfolio positioning.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
